샘플 요청 목록

 카트 문의
시장보고서
상품코드
1781365

세계의 고분자 바이오 분석 기술 시장

Large Molecule Bioanalytical Technologies
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 283 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

고분자 바이오 분석 기술 세계 시장은 2030년까지 159억 달러에 달할 전망

2024년에 88억 달러로 추정되는 고분자 바이오 분석 기술 세계 시장은 2024년부터 2030년까지 CAGR 10.3%로 성장하여 2030년에는 159억 달러에 달할 것으로 예측됩니다. 고분자 바이오 분석 기술 제품은 이 보고서에서 분석한 부문 중 하나로 CAGR 11.5%를 기록하며 분석 기간 종료시에는 118억 달러에 달할 것으로 예측됩니다. 고분자 바이오 분석 기술 서비스 분야의 성장률은 분석 기간 동안 CAGR 7.4%로 추정됩니다.

미국 시장은 24억 달러, 중국은 CAGR 14.2%로 성장 예측

미국의 고분자 바이오 분석 기술 시장은 2024년에 24억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 33억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 14.2%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 7.3%와 9.2%로 예측됩니다. 유럽에서는 독일이 CAGR 약 8.2%로 성장할 것으로 예측됩니다.

세계의 고분자 바이오 분석 기술 시장 - 주요 동향과 촉진요인 정리

고분자 바이오 분석 기술은 과학의 발전과 함께 어떻게 진화하고 있는가?

고분자 바이오 분석 분야는 생물학적 제제, 바이오시밀러, 유전자 치료의 과학적 진보에 힘입어 큰 변화의 시기를 맞이하고 있습니다. 액체 크로마토그래피 질량분석(LC-MS) 및 리간드 결합 분석(LBA)과 같은 고감도 분석 플랫폼은 복잡한 생체분자를 보다 정확하게 정량할 수 있게 해줍니다. 바이오 분석 워크플로우에서 자동화와 인공지능의 통합은 정확도를 높이고, 인적 오류를 줄이며, 처리량을 향상시키고 있습니다. 또한, 크로마토그래피, 분광분석, 면역분석을 결합한 하이브리드 분석 기술의 등장은 기존 바이오 분석법의 한계를 극복하고 있습니다. 규제 당국 또한 더 높은 분석 기준을 요구하고 있으며, 이는 보다 강력한 검증 방법의 개발로 이어지고 있습니다. 고분자 치료제가 바이오의약품 규제 상황을 계속 지배하는 가운데, 바이오 분석 기술은 더욱 정교한 의약품 개발 및 규제 준수 요구 사항을 지원하기 위해 진화하고 있습니다.

고분자 바이오 분석 기술에 대한 산업 전반의 수요가 증가하는 이유는 무엇일까?

의약품 개발에서 생물학적 제제와 바이오시밀러에 대한 의존도가 높아짐에 따라 첨단 바이오 분석 기술에 대한 수요가 급증하고 있습니다. 제약 및 생명공학 업계는 단클론항체, 펩타이드, 유전자 치료제의 개발, 특성화, 품질 관리를 지원하는 분석 솔루션에 대한 투자를 늘리고 있습니다. 또한, 맞춤형 의료와 바이오마커 기반 연구의 확대로 인해 특이성이 높고 민감도가 높은 분석 플랫폼의 필요성이 대두되고 있습니다. FDA 및 EMA와 같은 규제 당국은 엄격한 바이오 분석 검증 요건을 요구하고 있으며, 이는 정교한 바이오 분석 워크플로우의 채택을 촉진하고 있습니다. 또한, 암, 자가면역질환 등 만성질환의 증가로 인해 생물학적 제제 연구가 가속화되고 있으며, 이에 따라 고분자 바이오 분석 시장이 확대되고 있습니다. 정밀의료가 대중화되면서 바이오 분석 기술은 고분자 치료제의 유효성, 안전성, 재현성을 확보하기 위해 필수적인 요소로 자리 잡고 있습니다.

고분자 바이오 분석 시장이 직면한 주요 과제는 무엇인가?

분석 기술의 발전에도 불구하고, 고분자 바이오 분석 시장은 성장과 채택에 영향을 미치는 몇 가지 과제에 직면해 있습니다. 한 가지 큰 우려는 고도로 전문화된 장비와 전문 지식을 필요로 하는 고분자 특성 분석의 복잡성입니다. 광범위한 샘플 조제의 필요성과 장기간의 분석 개발 기간으로 인해 의약품 개발 일정이 지연될 수 있습니다. 또한, 특히 소규모 생명공학 기업 및 연구기관은 첨단 바이오 분석 장비의 구입 및 유지보수 비용이 여전히 큰 장벽으로 작용하고 있습니다. 가이드라인의 진화로 인해 바이오 분석법의 지속적인 적응과 검증이 필요하기 때문에 또 다른 시급한 과제는 규제 준수입니다. 또한, 서로 다른 규제 지역 간에 표준화된 생물학적 분석 프로토콜이 없다는 점은 전 세계 생물학적 제제 개발을 더욱 복잡하게 만들고 있습니다. 이러한 과제를 극복하기 위해 업계는 효율성과 세계 규제 표준 준수를 강화하는 비용 효율적이고 자동화된 표준화된 분석 솔루션 개발에 주력하고 있습니다.

고분자 바이오 분석 기술 시장의 성장을 촉진하는 요인은 무엇인가?

고분자 바이오 분석 기술 시장의 성장은 생물학적 제제 파이프라인의 증가, 기술 발전, 규제 당국의 감시 강화 등 여러 요인에 의해 주도되고 있습니다. 특히 단클론항체, 백신, 유전자 치료제 등 바이오의약품 연구개발의 확대가 시장 성장의 주요 요인으로 작용하고 있습니다. 또한, 고해상도 질량분석기, 차세대 시퀀서 등 첨단 분석 플랫폼을 채택하여 보다 정확하고 신뢰할 수 있는 고분자 특성 분석이 가능해졌습니다. 규제 준수와 데이터 무결성에 대한 관심이 높아지면서 기업들은 재현성과 추적성을 보장하는 자동화된 바이오 분석 솔루션에 대한 투자를 늘리고 있습니다. 생물학적 분석 시험을 위탁연구기관(CRO)에 아웃소싱하는 추세도 제약회사들이 비용 효율적이고 확장성이 높은 분석 솔루션을 요구하면서 시장 확대에 박차를 가하고 있습니다. 또한, 바이오마커 기반 의약품 개발 및 동반진단에 대한 수요가 증가하면서 바이오 분석 워크플로우의 혁신이 가속화되고 있습니다. 바이오 제약기업들이 생물학적 제제를 계속 우선시하는 가운데, 첨단 바이오 분석 기술에 대한 수요가 증가하면서 신약개발의 미래가 형성될 것으로 예상됩니다.

부문

제품 및 서비스(고분자 바이오 분석 기술 제품, 고분자 바이오 분석 기술 서비스), 용도(생물학적 제제 용도, 올리고뉴클레오티드 유래 의약품 및 분자 용도, 바이러스 벡터 용도, 세포 및 유전자 치료 용도, 나노입자 및 폴리머 용도)

조사 대상 기업 사례

  • Agilent Technologies, Inc.
  • Avomeen
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Cergentis B.V.
  • Charles River Laboratories International, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Halo Labs
  • ICON plc
  • Intertek Group plc
  • Laboratory Corporation of America Holdings(Labcorp)
  • Merck KGaA
  • Precision NanoSystems
  • SCIEX
  • SGS SA
  • Solvias AG
  • Thermo Fisher Scientific Inc.
  • Verder Group
  • Wyatt Technology Corporation

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범을 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.08.07

Global Large Molecule Bioanalytical Technologies Market to Reach US$15.9 Billion by 2030

The global market for Large Molecule Bioanalytical Technologies estimated at US$8.8 Billion in the year 2024, is expected to reach US$15.9 Billion by 2030, growing at a CAGR of 10.3% over the analysis period 2024-2030. Large Molecule Bioanalytical Technologies Products, one of the segments analyzed in the report, is expected to record a 11.5% CAGR and reach US$11.8 Billion by the end of the analysis period. Growth in the Large Molecule Bioanalytical Technologies Services segment is estimated at 7.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.4 Billion While China is Forecast to Grow at 14.2% CAGR

The Large Molecule Bioanalytical Technologies market in the U.S. is estimated at US$2.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.3 Billion by the year 2030 trailing a CAGR of 14.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.3% and 9.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.2% CAGR.

Global Large Molecule Bioanalytical Technologies Market - Key Trends & Drivers Summarized

How Are Large Molecule Bioanalytical Technologies Evolving with Scientific Advancements?

The field of large molecule bioanalysis is undergoing significant transformation, driven by scientific advancements in biologics, biosimilars, and gene therapy. High-sensitivity analytical platforms such as liquid chromatography-mass spectrometry (LC-MS) and ligand binding assays (LBAs) are enabling more precise quantification of complex biomolecules. The integration of automation and artificial intelligence in bioanalytical workflows is enhancing accuracy, reducing human error, and increasing throughput. Additionally, the rise of hybrid analytical techniques that combine chromatography, spectrometry, and immunoassays is addressing the limitations of traditional bioanalytical methods. Regulatory agencies are also pushing for higher analytical standards, leading to the development of more robust validation methodologies. As large molecule therapeutics continue to dominate the biopharmaceutical landscape, bioanalytical technologies are evolving to support more sophisticated drug development and regulatory compliance requirements.

Why Is Demand for Large Molecule Bioanalytical Technologies Increasing Across Industries?

The growing reliance on biologics and biosimilars in drug development has created an urgent demand for advanced bioanalytical technologies. The pharmaceutical and biotechnology industries are increasingly investing in analytical solutions to support the development, characterization, and quality control of monoclonal antibodies, peptides, and gene therapies. Additionally, the expansion of personalized medicine and biomarker-driven research is fueling the need for highly specific and sensitive analytical platforms. Regulatory authorities such as the FDA and EMA are mandating stringent bioanalytical validation requirements, driving the adoption of sophisticated bioanalytical workflows. Furthermore, the increasing incidence of chronic diseases, including cancer and autoimmune disorders, is accelerating biologics research, which in turn is expanding the market for large molecule bioanalysis. As precision medicine gains traction, bioanalytical technologies are becoming indispensable in ensuring the efficacy, safety, and reproducibility of large molecule therapeutics.

What Are the Key Challenges Facing the Large Molecule Bioanalytical Market?

Despite advancements in analytical technologies, the large molecule bioanalytical market faces several challenges that impact its growth and adoption. One major concern is the complexity of large molecule characterization, which requires highly specialized instrumentation and expertise. The need for extensive sample preparation and prolonged assay development times can lead to delays in drug development timelines. Additionally, the cost of acquiring and maintaining advanced bioanalytical instruments remains a significant barrier, particularly for smaller biotech firms and research institutions. Another pressing challenge is regulatory compliance, as evolving guidelines require continuous adaptation and validation of bioanalytical methods. Moreover, the lack of standardized bioanalytical protocols across different regulatory regions adds further complexity to global biologics development. To overcome these challenges, industry players are focusing on developing cost-effective, automated, and standardized analytical solutions that enhance efficiency and compliance with global regulatory standards.

What Factors Are Driving the Growth of the Large Molecule Bioanalytical Technologies Market?

The growth in the large molecule bioanalytical technologies market is driven by several factors, including the increasing pipeline of biologic drugs, technological advancements, and rising regulatory scrutiny. The expansion of biopharmaceutical R&D, particularly in monoclonal antibodies, vaccines, and gene therapies, is a key contributor to market growth. Additionally, the adoption of advanced analytical platforms such as high-resolution mass spectrometry and next-generation sequencing is enabling more precise and reliable large molecule characterization. The increasing emphasis on regulatory compliance and data integrity is prompting companies to invest in automated bioanalytical solutions that ensure reproducibility and traceability. The growing trend of outsourcing bioanalytical testing to contract research organizations (CROs) is also fueling market expansion, as pharmaceutical companies seek cost-effective and scalable analytical solutions. Furthermore, the increasing demand for biomarker-based drug development and companion diagnostics is driving innovation in bioanalytical workflows. As biopharmaceutical companies continue to prioritize biologics, the demand for advanced bioanalytical technologies is expected to rise, shaping the future of drug discovery and development.

SCOPE OF STUDY:

The report analyzes the Large Molecule Bioanalytical Technologies market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product & Services (Large Molecule Bioanalytical Technologies Products, Large Molecule Bioanalytical Technologies Services); Application (Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application, Nanoparticles & Polymers Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • Agilent Technologies, Inc.
  • Avomeen
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Cergentis B.V.
  • Charles River Laboratories International, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Halo Labs
  • ICON plc
  • Intertek Group plc
  • Laboratory Corporation of America Holdings (Labcorp)
  • Merck KGaA
  • Precision NanoSystems
  • SCIEX
  • SGS SA
  • Solvias AG
  • Thermo Fisher Scientific Inc.
  • Verder Group
  • Wyatt Technology Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Large Molecule Bioanalytical Technologies - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Complexity of Biologics Throws the Spotlight on Advanced Large Molecule Bioanalytical Technologies
    • Expansion of Biopharmaceutical R&D Pipelines Propels Growth in Bioanalytical Testing Demand
    • Increasing Adoption of Monoclonal Antibodies Expands Addressable Market Opportunity for Analytical Services
    • Emergence of Cell and Gene Therapies Strengthens Business Case for High-Sensitivity Analytical Platforms
    • Growing Regulatory Focus on Biosimilar Characterization Drives Demand for Robust Analytical Validation Tools
    • Demand for High-Throughput Screening Platforms Accelerates Development of Automated Bioanalytical Workflows
    • Advances in Mass Spectrometry Technologies Drive Adoption in Quantitative Large Molecule Assays
    • Rise in Outsourcing of Bioanalytical Services Spurs Growth in CRO Partnerships and Technology Transfer
    • Regulatory Emphasis on Data Integrity and Traceability Generates Demand for Digital Laboratory Solutions
    • Need for Greater Assay Specificity and Sensitivity Fuels Innovation in Ligand Binding Assays (LBA) and Hybrid Assays
    • Expansion of Global Biomanufacturing Capacity Drives Need for Reliable Pharmacokinetics (PK) and Immunogenicity Testing
    • Growth of Precision Medicine Initiatives Propels Adoption of Customized Bioanalytical Solutions
    • Increasing Emphasis on Early-Stage Biomarker Discovery Expands Use of Multiplexed Detection Platforms
    • Integration of AI and Machine Learning Strengthens Business Case for Predictive Bioanalytical Modeling Tools
    • Escalating Demand for Faster Time-to-Results Accelerates Adoption of Rapid Analytical Methods
    • Regulatory Harmonization Initiatives Across Markets Create Opportunities for Standardized Methodologies
    • Growth in Biologic Drug Approvals Sustains Demand for Advanced Method Development and Validation Support
    • Innovations in Sample Preparation and Microfluidics Drive Efficiency Gains in Complex Matrices Analysis
    • Rising Importance of Anti-Drug Antibody (ADA) Testing Spurs Technological Advancements in Immunogenicity Assays
    • Evolution of Bioanalytical Techniques to Support ADCs and Fusion Proteins Expands Technological Scope
    • Increasing Adoption of LC-MS/MS in Clinical and Preclinical Bioanalysis Drives Method Optimization Investments
    • Expansion of Biotech Startups Strengthens Demand for Scalable, Outsourced Bioanalytical Testing Solutions
    • Focus on Compliance with FDA and EMA Guidelines Propels Development of Audit-Ready Analytical Infrastructure
    • Growing Use of Bioreactors and Continuous Processing Technologies Creates Demand for Real-Time Analytical Monitoring
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Large Molecule Bioanalytical Technologies Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Large Molecule Bioanalytical Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Large Molecule Bioanalytical Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Large Molecule Bioanalytical Technologies Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Large Molecule Bioanalytical Technologies Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Large Molecule Bioanalytical Technologies Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Large Molecule Bioanalytical Technologies Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Biologics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Biologics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Biologics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Oligonucleotide Derived Drugs & Molecules Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Oligonucleotide Derived Drugs & Molecules Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Oligonucleotide Derived Drugs & Molecules Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Viral Vector Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Viral Vector Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Viral Vector Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cell & Gene Therapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Cell & Gene Therapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Cell & Gene Therapy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Nanoparticles & Polymers Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Nanoparticles & Polymers Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Nanoparticles & Polymers Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Large Molecule Bioanalytical Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Large Molecule Bioanalytical Technologies by Product & Services - Percentage Breakdown of Value Sales for Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Large Molecule Bioanalytical Technologies by Application - Percentage Breakdown of Value Sales for Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Large Molecule Bioanalytical Technologies by Product & Services - Percentage Breakdown of Value Sales for Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Large Molecule Bioanalytical Technologies by Application - Percentage Breakdown of Value Sales for Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application for the Years 2015, 2025 & 2030
  • JAPAN
    • Large Molecule Bioanalytical Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Large Molecule Bioanalytical Technologies by Product & Services - Percentage Breakdown of Value Sales for Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Large Molecule Bioanalytical Technologies by Application - Percentage Breakdown of Value Sales for Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application for the Years 2015, 2025 & 2030
  • CHINA
    • Large Molecule Bioanalytical Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Large Molecule Bioanalytical Technologies by Product & Services - Percentage Breakdown of Value Sales for Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Large Molecule Bioanalytical Technologies by Application - Percentage Breakdown of Value Sales for Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application for the Years 2015, 2025 & 2030
  • EUROPE
    • Large Molecule Bioanalytical Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Large Molecule Bioanalytical Technologies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Large Molecule Bioanalytical Technologies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Large Molecule Bioanalytical Technologies by Product & Services - Percentage Breakdown of Value Sales for Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Large Molecule Bioanalytical Technologies by Application - Percentage Breakdown of Value Sales for Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application for the Years 2015, 2025 & 2030
  • FRANCE
    • Large Molecule Bioanalytical Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Large Molecule Bioanalytical Technologies by Product & Services - Percentage Breakdown of Value Sales for Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Large Molecule Bioanalytical Technologies by Application - Percentage Breakdown of Value Sales for Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application for the Years 2015, 2025 & 2030
  • GERMANY
    • Large Molecule Bioanalytical Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Large Molecule Bioanalytical Technologies by Product & Services - Percentage Breakdown of Value Sales for Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Large Molecule Bioanalytical Technologies by Application - Percentage Breakdown of Value Sales for Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Large Molecule Bioanalytical Technologies by Product & Services - Percentage Breakdown of Value Sales for Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Large Molecule Bioanalytical Technologies by Application - Percentage Breakdown of Value Sales for Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Large Molecule Bioanalytical Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Large Molecule Bioanalytical Technologies by Product & Services - Percentage Breakdown of Value Sales for Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Large Molecule Bioanalytical Technologies by Application - Percentage Breakdown of Value Sales for Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Large Molecule Bioanalytical Technologies by Product & Services - Percentage Breakdown of Value Sales for Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Large Molecule Bioanalytical Technologies by Application - Percentage Breakdown of Value Sales for Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Large Molecule Bioanalytical Technologies by Product & Services - Percentage Breakdown of Value Sales for Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Large Molecule Bioanalytical Technologies by Application - Percentage Breakdown of Value Sales for Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Large Molecule Bioanalytical Technologies by Product & Services - Percentage Breakdown of Value Sales for Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Large Molecule Bioanalytical Technologies by Application - Percentage Breakdown of Value Sales for Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Large Molecule Bioanalytical Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Large Molecule Bioanalytical Technologies by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Large Molecule Bioanalytical Technologies by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Large Molecule Bioanalytical Technologies by Product & Services - Percentage Breakdown of Value Sales for Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Large Molecule Bioanalytical Technologies by Application - Percentage Breakdown of Value Sales for Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Large Molecule Bioanalytical Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Large Molecule Bioanalytical Technologies by Product & Services - Percentage Breakdown of Value Sales for Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Large Molecule Bioanalytical Technologies by Application - Percentage Breakdown of Value Sales for Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application for the Years 2015, 2025 & 2030
  • INDIA
    • Large Molecule Bioanalytical Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Large Molecule Bioanalytical Technologies by Product & Services - Percentage Breakdown of Value Sales for Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Large Molecule Bioanalytical Technologies by Application - Percentage Breakdown of Value Sales for Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Large Molecule Bioanalytical Technologies by Product & Services - Percentage Breakdown of Value Sales for Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Large Molecule Bioanalytical Technologies by Application - Percentage Breakdown of Value Sales for Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Large Molecule Bioanalytical Technologies by Product & Services - Percentage Breakdown of Value Sales for Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Large Molecule Bioanalytical Technologies by Application - Percentage Breakdown of Value Sales for Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Large Molecule Bioanalytical Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Large Molecule Bioanalytical Technologies by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Large Molecule Bioanalytical Technologies by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Large Molecule Bioanalytical Technologies by Product & Services - Percentage Breakdown of Value Sales for Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Large Molecule Bioanalytical Technologies by Application - Percentage Breakdown of Value Sales for Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Large Molecule Bioanalytical Technologies by Product & Services - Percentage Breakdown of Value Sales for Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Large Molecule Bioanalytical Technologies by Application - Percentage Breakdown of Value Sales for Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Large Molecule Bioanalytical Technologies by Product & Services - Percentage Breakdown of Value Sales for Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Large Molecule Bioanalytical Technologies by Application - Percentage Breakdown of Value Sales for Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Large Molecule Bioanalytical Technologies by Product & Services - Percentage Breakdown of Value Sales for Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Large Molecule Bioanalytical Technologies by Application - Percentage Breakdown of Value Sales for Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Large Molecule Bioanalytical Technologies by Product & Services - Percentage Breakdown of Value Sales for Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Large Molecule Bioanalytical Technologies by Application - Percentage Breakdown of Value Sales for Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Large Molecule Bioanalytical Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Large Molecule Bioanalytical Technologies by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Large Molecule Bioanalytical Technologies by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Large Molecule Bioanalytical Technologies by Product & Services - Percentage Breakdown of Value Sales for Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Large Molecule Bioanalytical Technologies by Application - Percentage Breakdown of Value Sales for Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Large Molecule Bioanalytical Technologies by Product & Services - Percentage Breakdown of Value Sales for Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Large Molecule Bioanalytical Technologies by Application - Percentage Breakdown of Value Sales for Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Large Molecule Bioanalytical Technologies by Product & Services - Percentage Breakdown of Value Sales for Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Large Molecule Bioanalytical Technologies by Application - Percentage Breakdown of Value Sales for Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Large Molecule Bioanalytical Technologies by Product & Services - Percentage Breakdown of Value Sales for Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Large Molecule Bioanalytical Technologies by Application - Percentage Breakdown of Value Sales for Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Large Molecule Bioanalytical Technologies by Product & Services - Percentage Breakdown of Value Sales for Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Large Molecule Bioanalytical Technologies by Application - Percentage Breakdown of Value Sales for Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Large Molecule Bioanalytical Technologies by Product & Services - Percentage Breakdown of Value Sales for Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Large Molecule Bioanalytical Technologies by Application - Percentage Breakdown of Value Sales for Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application for the Years 2015, 2025 & 2030
  • AFRICA
    • Large Molecule Bioanalytical Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Large Molecule Bioanalytical Technologies by Product & Services - Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Large Molecule Bioanalytical Technologies by Product & Services - Percentage Breakdown of Value Sales for Large Molecule Bioanalytical Technologies Products and Large Molecule Bioanalytical Technologies Services for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Large Molecule Bioanalytical Technologies by Application - Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Large Molecule Bioanalytical Technologies by Application - Percentage Breakdown of Value Sales for Biologics Application, Oligonucleotide Derived Drugs & Molecules Application, Viral Vector Application, Cell & Gene Therapy Application and Nanoparticles & Polymers Application for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제